AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Setchell, K. D.
Right arrow Articles by Heubi, J. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Setchell, K. D.
Right arrow Articles by Heubi, J. E
Agricola
Right arrow Articles by Setchell, K. D.
Right arrow Articles by Heubi, J. E
American Journal of Clinical Nutrition, Vol. 76, No. 2, 447-453, August 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability1,2,3

Kenneth DR Setchell, Nadine M Brown, Linda Zimmer-Nechemias, Wayne T Brashear, Brian E Wolfe, Abby S Kirschner and James E Heubi

1 From the Divisions of Clinical Mass Spectrometry (KDRS, NMB, LZ-N, WTB, BEW, and ASK) and Gastroenterology and Nutrition (JEH), Department of Pediatrics, Children’s Hospital Medical Center, Cincinnati.

Background: The isoflavones daidzein and genistein occur naturally in most soyfoods, conjugated almost exclusively to sugars. Controversy exists regarding the extent of bioavailability of isoflavone glycosides, and the mechanism of intestinal absorption of isoflavones in humans is unclear. Evidence from intestinal perfusion and in vitro cell culture studies indicates that isoflavone glycosides are poorly absorbed, yet isoflavones are bioavailable and appear in high concentrations in plasma, irrespective of whether they are ingested as aglycones or glycoside conjugates.

Objective: The objective was to determine whether isoflavone glycosides are absorbed from the intestine intact and reach the peripheral circulation unchanged.

Design: Plasma was collected at timed intervals before and after healthy adults ingested 50 mg of one of the isoflavone ß-glycosides (daidzin or genistin) or 250 mL soymilk containing mainly isoflavone glycosides. Electrospray ionization mass spectrometry was used to detect daidzin and genistin after solid-phase extraction of these conjugates from plasma. Bioavailability of isoflavones was confirmed by gas chromatography–mass spectrometry analysis.

Results: Specific and sensitive electrospray mass spectrometry failed to detect even traces of daidzin or genistin in plasma collected 1, 2, and 8 h after their ingestion as pure compounds or in a soyfood matrix. However, plasma was enriched in isoflavones that were hydrolyzable with a combined ß-glucuronidase and sulfatase enzyme preparation.

Conclusion: Isoflavone glycosides are not absorbed intact across the enterocyte of healthy adults, and their bioavailability requires initial hydrolysis of the sugar moiety by intestinal ß-glucosidases for uptake to the peripheral circulation.

Key Words: Phytoestrogens • isoflavones • ß-glycosides • daidzein • genistein • daidzin • genistin • absorption • soyfoods • soymilk • adults




This article has been cited by other articles:


Home page
J. Nutr.Home page
K. D. R. Setchell, X. Zhao, S. E. Shoaf, and K. Ragland
The Pharmacokinetics of S-(-)Equol Administered as SE5-OH Tablets to Healthy Postmenopausal Women
J. Nutr., November 1, 2009; 139(11): 2037 - 2043.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. D. Setchell, X. Zhao, P. Jha, J. E Heubi, and N. M Brown
The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers
Am. J. Clinical Nutrition, October 1, 2009; 90(4): 1029 - 1037.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Jamadar-Shroff, M. G. Papich, and S. E. Suter
Soy-Derived Isoflavones Inhibit the Growth of Canine Lymphoid Cell Lines
Clin. Cancer Res., February 15, 2009; 15(4): 1269 - 1276.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
C. E. Gleason, C. M. Carlsson, J. H. Barnet, S. A. Meade, K. D. R. Setchell, C. S. Atwood, S. C. Johnson, M. L. Ries, and S. Asthana
A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women
Age Ageing, January 1, 2009; 38(1): 86 - 93.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. Hosoda, T. Furuta, A. Yokokawa, K. Ogura, A. Hiratsuka, and K. Ishii
Plasma Profiling of Intact Isoflavone Metabolites by High-Performance Liquid Chromatography and Mass Spectrometric Identification of Flavone Glycosides Daidzin and Genistin in Human Plasma after Administration of Kinako
Drug Metab. Dispos., August 1, 2008; 36(8): 1485 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Int. J. Syst. Evol. Microbiol.Home page
T. Maruo, M. Sakamoto, C. Ito, T. Toda, and Y. Benno
Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella
Int J Syst Evol Microbiol, May 1, 2008; 58(5): 1221 - 1227.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. E Rufer, A. Bub, J. Moseneder, P. Winterhalter, M. Sturtz, and S. E Kulling
Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1314 - 1323.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. Coxam
Current Data with Inulin-Type Fructans and Calcium, Targeting Bone Health in Adults
J. Nutr., November 1, 2007; 137(11): 2527S - 2533S.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Enokizono, H. Kusuhara, and Y. Sugiyama
Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens
Mol. Pharmacol., October 1, 2007; 72(4): 967 - 975.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Clerici, K. D. R. Setchell, P. M. Battezzati, M. Pirro, V. Giuliano, S. Asciutti, D. Castellani, E. Nardi, G. Sabatino, S. Orlandi, et al.
Pasta Naturally Enriched with Isoflavone Aglycons from Soy Germ Reduces Serum Lipids and Improves Markers of Cardiovascular Risk
J. Nutr., October 1, 2007; 137(10): 2270 - 2278.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Kottra and H. Daniel
Flavonoid Glycosides Are Not Transported by the Human Na+/Glucose Transporter When Expressed in Xenopus laevis Oocytes, but Effectively Inhibit Electrogenic Glucose Uptake
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 829 - 835.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. R Walsh, S. J Haak, T. Bohn, Q. Tian, S. J Schwartz, and M. L Failla
Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1050 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. M. C. Geuns, J. Buyse, A. Vankeirsbilck, and E. H. M. Temme
Metabolism of Stevioside by Healthy Subjects
Experimental Biology and Medicine, January 1, 2007; 232(1): 164 - 173.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. K. Prasain, J. Xu, M. Kirk, M. Smith Johnson, J. Sfakianos, and S. Barnes
Differential Biliary Excretion of Genistein Metabolites Following Intraduodenal and Intravenous Infusion of Genistin in Female Rats
J. Nutr., December 1, 2006; 136(12): 2975 - 2979.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Kano, T. Takayanagi, K. Harada, S. Sawada, and F. Ishikawa
Bioavailability of Isoflavones after Ingestion of Soy Beverages in Healthy Adults
J. Nutr., September 1, 2006; 136(9): 2291 - 2296.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. D. R. Setchell and S. J. Cole
Method of Defining Equol-Producer Status and Its Frequency among Vegetarians
J. Nutr., August 1, 2006; 136(8): 2188 - 2193.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Cassidy, J. E. Brown, A. Hawdon, M. S. Faughnan, L. J. King, J. Millward, L. Zimmer-Nechemias, B. Wolfe, and K. D.R. Setchell
Factors Affecting the Bioavailability of Soy Isoflavones in Humans after Ingestion of Physiologically Relevant Levels from Different Soy Foods
J. Nutr., January 1, 2006; 136(1): 45 - 51.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Reimann, J. Dierkes, A. Carlsohn, D. Talbot, M. Ferrari, J. Hallund, W. L. Hall, K. Vafeiadou, U. Huebner, F. Branca, et al.
Consumption of Soy Isoflavones Does Not Affect Plasma Total Homocysteine or Asymmetric Dimethylarginine Concentrations in Healthy Postmenopausal Women
J. Nutr., January 1, 2006; 136(1): 100 - 105.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Clavel, M. Fallani, P. Lepage, F. Levenez, J. Mathey, V. Rochet, M. Serezat, M. Sutren, G. Henderson, C. Bennetau-Pelissero, et al.
Isoflavones and Functional Foods Alter the Dominant Intestinal Microbiota in Postmenopausal Women
J. Nutr., December 1, 2005; 135(12): 2786 - 2792.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. D. Setchell, C. Clerici, E. D Lephart, S. J Cole, C. Heenan, D. Castellani, B. E Wolfe, L. Nechemias-Zimmer, N. M Brown, T. D Lund, et al.
S-Equol, a potent ligand for estrogen receptor {beta}, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora
Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1072 - 1079.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 230S - 242S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer
Plasma Phytoestrogens Are Not Altered by Probiotic Consumption in Postmenopausal Women with and without a History of Breast Cancer
J. Nutr., August 1, 2004; 134(8): 1998 - 2003.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. L. Bemis, J. L. Capodice, M. Desai, R. Buttyan, and A. E. Katz
A Concentrated Aglycone Isoflavone Preparation (GCP) That Demonstrates Potent Anti-Prostate Cancer Activity In vitro and In vivo
Clin. Cancer Res., August 1, 2004; 10(15): 5282 - 5292.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. A Kroon, M. N Clifford, A. Crozier, A. J Day, J. L Donovan, C. Manach, and G. Williamson
How should we assess the effects of exposure to dietary polyphenols in vitro?
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez
Polyphenols: food sources and bioavailability
Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. Zheng, J. Hu, P. A. Murphy, D. L. Alekel, W. D. Franke, and S. Hendrich
Rapid Gut Transit Time and Slow Fecal Isoflavone Disappearance Phenotype Are Associated with Greater Genistein Bioavailability in Women
J. Nutr., October 1, 2003; 133(10): 3110 - 3116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. D. Setchell and E. Lydeking-Olsen
Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 593S - 609.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. D. R. Setchell, N. M. Brown, P. B. Desai, L. Zimmer-Nechimias, B. Wolfe, A. S. Jakate, V. Creutzinger, and J. E. Heubi
Bioavailability, Disposition, and Dose-Response Effects of Soy Isoflavones When Consumed by Healthy Women at Physiologically Typical Dietary Intakes
J. Nutr., April 1, 2003; 133(4): 1027 - 1035.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen
The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones
J. Nutr., December 1, 2002; 132(12): 3577 - 3584.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition